The holding company is coming down. Moonshot AI, the Chinese artificial-intelligence startup behind the Kimi assistant, has notified shareholders that it plans to dismantle its variable-interest-entity and red-chip structure, according to a report by Digitimes on Thursday — a reorganization aimed at clearing the regulatory path for an initial public offering, most likely in Hong Kong. The move follows a 20-billion-yuan funding round that valued the company at more than $20 billion, according to people familiar with the matter.
The restructuring is the latest sign that China’s AI startups are preparing for public markets after two years of heavy private funding. Moonshot, one of the country’s “AI six little dragons” — the six most prominent AI startups, alongside Zhipu AI, MiniMax, StepFun, Baichuan and 01.AI — has raised roughly 39 billion yuan, about $5.4 billion, over the past six months, and its valuation has more than doubled since its last major round. Taking down the offshore shell is the technical work that must happen before a listing can begin.
What the VIE unwind means
Chinese technology companies have traditionally listed abroad using a variable-interest-entity structure, in which offshore entities hold contractual control over domestic operating companies whose business licenses are restricted to Chinese ownership. Regulators in Beijing have spent the past several years tightening scrutiny of such structures, and companies seeking domestic or Hong Kong listings have increasingly unwound them to comply with new data-security and listing rules.
For Moonshot, the restructuring serves two purposes. It brings the company’s ownership into line with Chinese requirements on where sensitive AI and data businesses can be held, and it removes the uncertainty that VIE arrangements carry for prospective investors. The company has told shareholders that the offshore framework will be dissolved and replaced with a structure that can support a Hong Kong listing, according to the Digitimes report.
The funding context
The move comes on the back of an extraordinary capital raise. Moonshot closed a 20-billion-yuan round this spring at a valuation exceeding $20 billion, and the six-month total of roughly 39 billion yuan makes it one of the best-funded AI startups outside the United States. The money has gone into model training, compute procurement and the expansion of Kimi, the assistant that has become one of China’s most widely used consumer AI products.
The valuation reflects the market’s appetite for Chinese AI after DeepSeek’s open-weight models reset expectations about what domestic labs can achieve. Investors who once treated China’s AI sector as a follower of American labs have begun pricing in the possibility that several Chinese companies will be viable long-term competitors, and Moonshot is among the names at the top of that list. Its funding round was oversubscribed, according to people familiar with the terms, with participation from state-linked funds and major private investors.
Why Hong Kong
Hong Kong has become the default destination for Chinese tech companies seeking public listings, and for good reason: it offers access to international capital without the political exposure of a New York listing, and Beijing has signaled support for Hong Kong as a listing venue for its technology champions. The city has seen a steady stream of AI and technology IPOs as mainland companies test the market’s appetite.
A Moonshot listing would test how far that appetite extends. The company is loss-making, like most frontier AI labs, and its valuation of more than $20 billion would make it one of the largest AI listings in Asia if it comes to market at that level. Bankers say the deal would be a benchmark for how Hong Kong values Chinese AI companies — whether they are priced on revenue, on user numbers or on the strategic premium investors assign to domestic AI leadership.
The competitive picture
The IPO preparations also reflect the pressure building in China’s AI market. DeepSeek has become the country’s most talked-about model developer, Zhipu and MiniMax have built substantial enterprise businesses, and the government has pushed all of them toward commercialization. Raising public capital gives Moonshot a funding base that does not depend on the goodwill of private investors, and it puts the company on a footing to match rivals’ spending on compute and talent.
There are risks in going public first. Chinese AI companies face scrutiny over data practices, export controls on the chips they need, and the possibility that regulators will impose new rules on AI products. A public listing exposes those risks to a wider audience of investors, and the price of the stock will be a running referendum on the sector’s health. Moonshot’s management has said it is committed to the listing timeline, but people familiar with the process caution that the timing depends on market conditions and regulatory approvals that remain uncertain.
For the broader industry, the significance is structural. China’s AI labs have been funded by a mix of state capital, corporate investors and venture funds, and a successful Moonshot IPO would open the door for the rest of the group — Zhipu, MiniMax and the others — to follow. The unwinding of the VIE is the quiet, unglamorous first step of that process: paperwork before fireworks. But in a sector where access to capital determines who gets to train the next generation of models, the paperwork matters as much as the models.
